In another attempt at quelling public outcry over the skyrocketing price of the lifesaving EpiPen, maker Mylan has announced that it will begin selling a generic version of its allergy medication injector ‒
at the low, low cost of $300.EpiPen administers a quick dose of epinephrine to counter a severe, life-threatening allergic reaction known as anaphylactic shock.
The easy-to-use injector is made by West Virginia-based Mylan Pharmaceuticals, which bought the rights to it in 2007. Since then, the price of the EpiPen has ballooned, going from $100 to $600.On Monday, Mylan unveiled the generic version, noting that the auto-injector's "list price of $300" for each two-pack carton "represents a discount of more than 50 percent to the Mylan list price."
"We understand the deep frustration and concerns associated with the cost of EpiPen to the patient, and have always shared the public's desire to ensure that this important product be accessible to anyone who needs it," CEO Heather Bresch said in a
statement. "Our decision to launch a generic alternative to EpiPen is an extraordinary commercial response."
The generic version will be identical to the branded one ‒ at both the 0.15-mg and 0.30-mg dosages ‒ and will be launched in "several weeks," after the company completes labeling revisions.
Comment: The Western security services have finally had their wish come true. With people going off for random reasons, terror attacks happening all over the world, and the security services manufacturing false flags, people are scared, even justifiably so, to a degree. Sure, you're probably still more likely to die from heart disease, but the news-catching quality of these events has an effect on public perception. And when people face a threat they identify as coming from some external enemy, they naturally turn toward their corrupt leaders for protection, despite the fact that those very leaders created the threat in the first place.